Dual-target ADC shows promising PFS signal in mCRPC | ASCO 2026 | Managed Healthcare Executive
Dual-target ADC shows promising PFS signal in mCRPC | ASCO 2026 | Managed Healthcare Executive
1 month ago
managedhealthcareexecutive.com
Building cell and gene therapy programs takes early planning, strategic risk decisions and careful growth | Managed Healthcare Executive
Building cell and gene therapy programs takes early planning, strategic risk decisions and careful growth | Managed Healthcare Executive
4 months ago
managedhealthcareexecutive.com
Diabetes' Economic Burden and the Rise of CGM Devices | Managed Healthcare Executive
Diabetes' Economic Burden and the Rise of CGM Devices | Managed Healthcare Executive
3 months ago
managedhealthcareexecutive.com
Facing the practical problems of gene therapy | AMCP Annual 2026 | Managed Healthcare Executive
Facing the practical problems of gene therapy | AMCP Annual 2026 | Managed Healthcare Executive
2 months ago
managedhealthcareexecutive.com
From Clinical Trials to Community Practice: Contextualizing Lorlatinib's Durability and Implementing Long-Term Management Strategies | Managed Healthcare Executive
1:30
From Clinical Trials to Community Practice: Contextualizing Lorlatinib's Durability and Implementing Long-Term Management Strategies | Managed Healthcare Executive
2 weeks ago
managedhealthcareexecutive.com
Expert flags concerns over 'bananas' 340B program growth and oversight | Asembia AXS26 Summit | Managed Healthcare Executive
Expert flags concerns over 'bananas' 340B program growth and oversight | Asembia AXS26 Summit | Managed Healthcare Executive
2 months ago
managedhealthcareexecutive.com
HealthDyne foresees rapid growth in its direct-to-employer business, 50,000 lives now and a million in the pipeline | Asembia AXS26 Summit | Managed Healthcare Executive
HealthDyne foresees rapid growth in its direct-to-employer business, 50,000 lives now and a million in the pipeline | Asembia AXS26 Summit | Managed Healthcare Executive
2 months ago
managedhealthcareexecutive.com
Specialty pharmacy care model improves diabetes outcomes while lowering costs | Asembia AXS2026 Summit | Managed Healthcare Executive
2 months ago
managedhealthcareexecutive.com
Navitus’ Sharon Faust talks about trends in GLP-1 spend | Managed Healthcare Executive
1 month ago
managedhealthcareexecutive.com
VDPHL01 shows faster, stronger hair growth vs standard minoxidil, CEO says | AAD 2026 | Managed Healthcare Executive
3 months ago
managedhealthcareexecutive.com
Care Without Delay program, 'succinct' value-based guides are key to Risant Health's value-based care push, says CEO Jaewon Ryu, M.D., J.D. | Managed Healthcare Executive
4 months ago
managedhealthcareexecutive.com
The next steps for this investigational lung cancer treatment | ASCO 2026 | Managed Healthcare Executive
1 month ago
managedhealthcareexecutive.com
A multidimensional way of assessing pain | Managed Healthcare Executive
2 weeks ago
managedhealthcareexecutive.com
CAR-T cell therapy moves beyond hospitals, raising new questions for payers | AMCP Annual 2026 | Managed Healthcare Executive
2 months ago
managedhealthcareexecutive.com
Survodutide targets visceral and liver fat, not just weight: Carel le Roux, Ph.D. | ADA 2026 | Managed Healthcare Executive
1 month ago
managedhealthcareexecutive.com
CGM's A1C impact in CONNECT trial rivals effective non-insulin treatments: Thomas Martens, M.D. | ADA 2026 | Managed Healthcare Executive
3 weeks ago
managedhealthcareexecutive.com
What potential PBM changes could mean for employers | Asembia AXS26 Summit | Managed Healthcare Executive
2 months ago
managedhealthcareexecutive.com
Lee Kaplan, M.D., discusses the metabolic case for survodutide | ADA 2026 | Managed Healthcare Executive
1 month ago
managedhealthcareexecutive.com
A look at past and present HIV prevention therapies | AMCP Annual 2026 | Managed Healthcare Executive
2 months ago
managedhealthcareexecutive.com
The idea of value-based care appeals to dermatologists. The current reality? Not so much, says Marta J. Van Beek, M.D., M.P.H. | AAD 2026 | Managed Healthcare Executive
3 months ago
managedhealthcareexecutive.com
Early data show vaccine has potential to prevent Lynch-related cancers | ASCO 2026 | Managed Healthcare Executive
1 month ago
managedhealthcareexecutive.com
Daraxonrasib trial exceeds expectations after decades of disappointment in pancreatic cancer drug development | Managed Healthcare Executive
1 month ago
managedhealthcareexecutive.com
Spending on behavioral health 'blew the doors off' of the funding system. Now the state of Oregon and CareOregon are figuring what to do, says CareOregon president and CEO Eric C.Hunter | Managed Healthcare Executive
4 months ago
managedhealthcareexecutive.com
Orexin agonists among “exciting” emerging therapies for narcolepsy type 1 | AMCP Annual 2026 | Managed Healthcare Executive
2 months ago
managedhealthcareexecutive.com
An overview of the prevalence and treatment of multiple myeloma | Managed Healthcare Executive
2 months ago
managedhealthcareexecutive.com
Subgroup Analysis From the Phase 3 EMERALD Trial by Prior Duration of Endocrine Therapy Plus CDK4/6 Inhibitor | Managed Healthcare Executive
7 months ago
managedhealthcareexecutive.com
Evolving Guidelines: Impact of Gene Therapy and BCG Failure Redefinitions on High-Risk NMIBC Patient Management | Managed Healthcare Executive
1 year ago
managedhealthcareexecutive.com
Treatment Landscape of Crohn’s Disease and Mechanisms of Action | Managed Healthcare Executive
9 months ago
managedhealthcareexecutive.com
Aspirin for colorectal cancer prevention: Current use and its limitations | 2026 ASCO Gastrointestinal Cancers Symposium | Managed Healthcare Executive
5 months ago
managedhealthcareexecutive.com
Guideline Recommendations for the Treatment of Pulmonary Fibrosis | Managed Healthcare Executive
Feb 27, 2025
managedhealthcareexecutive.com
See more
Static thumbnail place holder